This study evaluates a temporary research-based intervention of universal ante-natal screening for sickle cell/thalassaemia in two areas of England of intermediate (1.29 per 10,000) and low (0.18 per 10,0000) expected ...

This paper is concerned with the formation of and processes of changes in professional identities, especially those professional groups associated with the new genetics, be they learned scientific professions, clinicians ...

An unexplained death in custody represents an important focal point for public scrutiny of the criminal justice system, especially when excess deaths occur in those of minority ethnic descent. Sickle cell anaemia is a ...

The work of Bruno Latour has animated debates in sociology, anthropology and philosophy over several decades, whilst attracting criticisms of the ontological, epistemological and political implications of his focus on ...

For sickle cell and thalassaemia, social science is critical if we wish to understand the social context of - and how people experience - the two conditions. Sickle cell and thalassaemia are more than simply ‘being of’, ...

Employers need to be flexible when managing sickle cell disease in the workplace and sensitive to the risks of discrimination. Diana De, Simon Dyson and Karl Atkin offer evidence-based guidance and recommendations.

Greater priority, and appropriate resources, need to be accorded to the provision of sickle cell and thalassaemia services. Sickle cell and thalassaemia disorders are among the most common genetic conditions in the world. ...

Sickle cell and thalassaemia are among the world’s most common genetic conditions. They are especially common in Africa, Brazil, the Caribbean, the Middle East and Asia. They affect all ethnic groups but they particularly ...

Sickle cell disease (SCD) is an inherited disorder affecting 2% of all babies born in Ghana. SCD is the commonest genetic condition of clinical and epidemiological importance in Africa, and over 95% of children born with ...

Sickle cell and thalassaemia are among the world’s leading genetic conditions with over five per cent of the world’s population carrying clinically significant haemoglobin gene variants (Modell and Darlison, 2008). In the ...